Cargando…

Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system

Three pathological grading systems advocated by Perzin/Szanto, Spiro, and van Weert are currently used for adenoid cystic carcinoma (AdCC). In these systems, the amount or presence of the solid tumor component in AdCC specimens is an important index. However, the “solid tumor component” has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Naruhiko, Murase, Takayuki, Ueda, Kaori, Nagao, Toshitaka, Kusafuka, Kimihide, Nakaguro, Masato, Urano, Makoto, Taguchi, Ken‐ichi, Yamamoto, Hidetaka, Kano, Satoshi, Tada, Yuichiro, Tsukahara, Kiyoaki, Okami, Kenji, Onitsuka, Tetsuro, Fujimoto, Yasushi, Kawakita, Daisuke, Sakurai, Kazuo, Nagao, Toru, Hanai, Nobuhiro, Kawata, Ryo, Hato, Naohito, Otsuki, Naoki, Nibu, Ken‐ichi, Inagaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935776/
https://www.ncbi.nlm.nih.gov/pubmed/33377247
http://dx.doi.org/10.1111/cas.14790
_version_ 1783661065578479616
author Morita, Naruhiko
Murase, Takayuki
Ueda, Kaori
Nagao, Toshitaka
Kusafuka, Kimihide
Nakaguro, Masato
Urano, Makoto
Taguchi, Ken‐ichi
Yamamoto, Hidetaka
Kano, Satoshi
Tada, Yuichiro
Tsukahara, Kiyoaki
Okami, Kenji
Onitsuka, Tetsuro
Fujimoto, Yasushi
Kawakita, Daisuke
Sakurai, Kazuo
Nagao, Toru
Hanai, Nobuhiro
Kawata, Ryo
Hato, Naohito
Otsuki, Naoki
Nibu, Ken‐ichi
Inagaki, Hiroshi
author_facet Morita, Naruhiko
Murase, Takayuki
Ueda, Kaori
Nagao, Toshitaka
Kusafuka, Kimihide
Nakaguro, Masato
Urano, Makoto
Taguchi, Ken‐ichi
Yamamoto, Hidetaka
Kano, Satoshi
Tada, Yuichiro
Tsukahara, Kiyoaki
Okami, Kenji
Onitsuka, Tetsuro
Fujimoto, Yasushi
Kawakita, Daisuke
Sakurai, Kazuo
Nagao, Toru
Hanai, Nobuhiro
Kawata, Ryo
Hato, Naohito
Otsuki, Naoki
Nibu, Ken‐ichi
Inagaki, Hiroshi
author_sort Morita, Naruhiko
collection PubMed
description Three pathological grading systems advocated by Perzin/Szanto, Spiro, and van Weert are currently used for adenoid cystic carcinoma (AdCC). In these systems, the amount or presence of the solid tumor component in AdCC specimens is an important index. However, the “solid tumor component” has not been well defined. Salivary AdCC cases (N = 195) were collected after a central pathology review. We introduced a novel criterion for solid tumor component, minAmax (minor axis maximum). The largest solid tumor nest in each AdCC case was histologically screened, the maximum oval fitting the solid nest was estimated, and the length of the minor axis of the oval (minAmax) was measured. The prognostic cutoff for the minAmax was determined using training and validation cohorts. All cases were evaluated for the four grading systems, and their prognostic impact and interobserver variability were examined. The cutoff value for the minAmax was set at 0.20 mm. Multivariate prognostic analyses showed the minAmax and van Weert systems to be independent prognostic tools for overall, disease‐free, and distant metastasis‐free survival while the Perzin/Szanto and Spiro systems were selected for overall survival but not for disease‐free or distant metastasis‐free survival. The highest hazard ratio for overall survival (11.9) was obtained with the minAmax system. The reproducibility of the minAmax system (kappa coefficient of 0.81) was scored as very good while those of the other three systems were scored as moderate. In conclusion, the minAmax is a simple, objective, and highly reproducible grading system useful for prognostic stratification for salivary AdCC.
format Online
Article
Text
id pubmed-7935776
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79357762021-03-15 Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system Morita, Naruhiko Murase, Takayuki Ueda, Kaori Nagao, Toshitaka Kusafuka, Kimihide Nakaguro, Masato Urano, Makoto Taguchi, Ken‐ichi Yamamoto, Hidetaka Kano, Satoshi Tada, Yuichiro Tsukahara, Kiyoaki Okami, Kenji Onitsuka, Tetsuro Fujimoto, Yasushi Kawakita, Daisuke Sakurai, Kazuo Nagao, Toru Hanai, Nobuhiro Kawata, Ryo Hato, Naohito Otsuki, Naoki Nibu, Ken‐ichi Inagaki, Hiroshi Cancer Sci Original Articles Three pathological grading systems advocated by Perzin/Szanto, Spiro, and van Weert are currently used for adenoid cystic carcinoma (AdCC). In these systems, the amount or presence of the solid tumor component in AdCC specimens is an important index. However, the “solid tumor component” has not been well defined. Salivary AdCC cases (N = 195) were collected after a central pathology review. We introduced a novel criterion for solid tumor component, minAmax (minor axis maximum). The largest solid tumor nest in each AdCC case was histologically screened, the maximum oval fitting the solid nest was estimated, and the length of the minor axis of the oval (minAmax) was measured. The prognostic cutoff for the minAmax was determined using training and validation cohorts. All cases were evaluated for the four grading systems, and their prognostic impact and interobserver variability were examined. The cutoff value for the minAmax was set at 0.20 mm. Multivariate prognostic analyses showed the minAmax and van Weert systems to be independent prognostic tools for overall, disease‐free, and distant metastasis‐free survival while the Perzin/Szanto and Spiro systems were selected for overall survival but not for disease‐free or distant metastasis‐free survival. The highest hazard ratio for overall survival (11.9) was obtained with the minAmax system. The reproducibility of the minAmax system (kappa coefficient of 0.81) was scored as very good while those of the other three systems were scored as moderate. In conclusion, the minAmax is a simple, objective, and highly reproducible grading system useful for prognostic stratification for salivary AdCC. John Wiley and Sons Inc. 2021-02-02 2021-03 /pmc/articles/PMC7935776/ /pubmed/33377247 http://dx.doi.org/10.1111/cas.14790 Text en © 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Morita, Naruhiko
Murase, Takayuki
Ueda, Kaori
Nagao, Toshitaka
Kusafuka, Kimihide
Nakaguro, Masato
Urano, Makoto
Taguchi, Ken‐ichi
Yamamoto, Hidetaka
Kano, Satoshi
Tada, Yuichiro
Tsukahara, Kiyoaki
Okami, Kenji
Onitsuka, Tetsuro
Fujimoto, Yasushi
Kawakita, Daisuke
Sakurai, Kazuo
Nagao, Toru
Hanai, Nobuhiro
Kawata, Ryo
Hato, Naohito
Otsuki, Naoki
Nibu, Ken‐ichi
Inagaki, Hiroshi
Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
title Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
title_full Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
title_fullStr Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
title_full_unstemmed Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
title_short Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system
title_sort pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: a proposal of an objective grading system
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935776/
https://www.ncbi.nlm.nih.gov/pubmed/33377247
http://dx.doi.org/10.1111/cas.14790
work_keys_str_mv AT moritanaruhiko pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT murasetakayuki pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT uedakaori pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT nagaotoshitaka pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT kusafukakimihide pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT nakaguromasato pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT uranomakoto pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT taguchikenichi pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT yamamotohidetaka pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT kanosatoshi pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT tadayuichiro pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT tsukaharakiyoaki pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT okamikenji pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT onitsukatetsuro pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT fujimotoyasushi pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT kawakitadaisuke pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT sakuraikazuo pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT nagaotoru pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT hanainobuhiro pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT kawataryo pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT hatonaohito pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT otsukinaoki pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT nibukenichi pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem
AT inagakihiroshi pathologicalevaluationoftumorgradeforsalivaryadenoidcysticcarcinomaaproposalofanobjectivegradingsystem